Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population
Dementia and Geriatric Cognitive Disorders Extra · 14.10.2020 · 10 (3) · 105-114
DOI: 10.1159/000506280 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dementia and Geriatric Cognitive Disorders Extra, online erschienen am 14.10.2020. Verfasst von Sebastian Bello-Lepe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Escuela de Fonoaudiología, Universidad de Valparaíso, Viña del Mar, Chile. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The Montreal Cognitive Assessment (MoCA) is a sensitive screening instrument for mild neurocognitive disorder (mild NCD). However, cut-off scores and accuracy indices should be established using representative samples of the population. In this context, the aim of this study was to update the normative values, and diagnostic efficiency statistics of the MoCA to detect mild NCD in the Chilean population.
Methods
This study included 226 participants from the north, center, and south of the country, classified into 3 groups: healthy elderly (HE; n = 113), mild NCD (n = 65), and major neurocognitive disorder (major NCD; n = 48).
Results
The optimal cut-off score to discriminate mild NCD from HE participants was 20 points with a sensitivity of 82.8% and a specificity of 84.1%. The observed balance between sensitivity and specificity shows a good test performance either to confirm or discard a diagnosis. The cut-off between mild NCD and major NCD from HE participants was 19 points with 85.6% of sensitivity and 90.3% of specificity.
Conclusion
Overall diagnostic accuracy can be considered as outstanding (AUC ≥0.904) when discriminating HE from both mild NCD and major NCD. These results showed that the MoCA is a suitable tool to identify mild NCD and major NCD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Facultad de Medicina, Escuela de Fonoaudiología, Universidad de Valparaíso, Viña del Mar, Chile.
- Psychology and Language Sciences Division, University College London, London, United Kingdom.
- Centro de Investigación del Desarrollo en Cognición y Lenguaje, CIDCL-UV, Facultad de Medicina, Universidad de Valparaíso, Viña del Mar, Chile.
- Escuela de Psicología, Universidad Arturo Prat, Iquique, Chile.
- Departamento de Psicología, Facultad de Ciencias Sociales, Universidad de Concepción, Concepción, Chile.
Zitieren
APA
Bello-Lepe, S., Alonso-Sánchez, M. F., Ortega, A., Gaete, M., Veliz, M., Lira, J., & Perez Salas, C. P. (2020). Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population. Dementia and Geriatric Cognitive Disorders Extra, 10(3), 105-114. https://doi.org/10.1159/000506280
Vancouver
Bello-Lepe S, Alonso-Sánchez MF, Ortega A, Gaete M, Veliz M, Lira J, et al. Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population. Dementia and Geriatric Cognitive Disorders Extra. 2020;10(3):105-114. doi:10.1159/000506280
BibTeX
@article{BelloLepe2020,
author = {Bello-Lepe, Sebastian and Alonso-Sánchez, María Francisca and Ortega, Alonso and Gaete, Marcelo and Veliz, Marcela and Lira, Juan and Perez Salas, Claudia Paz},
title = {Montreal Cognitive Assessment as Screening Measure for Mild and Major Neurocognitive Disorder in a Chilean Population},
journal = {Dementia and Geriatric Cognitive Disorders Extra},
year = {2020},
volume = {10},
number = {3},
pages = {105--114},
doi = {10.1159/000506280}
}
EUVIMED